Trial Outcomes & Findings for The Effectiveness of SMS in Improving Antiretroviral Medication Adherence Among Adolescents Living With HIV in Nigeria (NCT NCT03394391)

NCT ID: NCT03394391

Last Updated: 2019-11-15

Results Overview

ART adherence is assessed by different well-validated methods. In this study, ART adherence will be measured, primarily, using the self-report visual analog scale. The scale is well-validated, self-report of the level of ART adherence with a range from 0 to 100%. While higher values indicate better levels of adherence, patients with adherence levels of 95% and above are regarded as ART-adherent while those with values less than 95% are not adherent to ART medications. Viral load is the number of copies of viral RNA detected in participants' blood. Participants with viral load \</=20 copies per ml are regarded to have optimal viral suppression indicative of optimal adherence to medications.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

212 participants

Primary outcome timeframe

20week [End of study]

Results posted on

2019-11-15

Participant Flow

Participants were recruited while attending routine clinic visits across five (5) high patient-density ART sites in 2 States in South West, Nigeria over a 13 week period.

There was no significant event.

Participant milestones

Participant milestones
Measure
Intervention Group
Daily ART-adherence SMS reminder Daily ART-adherence SMS reminder: Interactive and tailored SMS reminders that are acceptable to the participants to remind them to take their medications and to make clinic attendance. Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit. All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
Control Group
Standard adherence counselling/Patient experience group chat Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit. All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
Overall Study
STARTED
106
106
Overall Study
COMPLETED
105
104
Overall Study
NOT COMPLETED
1
2

Reasons for withdrawal

Reasons for withdrawal
Measure
Intervention Group
Daily ART-adherence SMS reminder Daily ART-adherence SMS reminder: Interactive and tailored SMS reminders that are acceptable to the participants to remind them to take their medications and to make clinic attendance. Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit. All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
Control Group
Standard adherence counselling/Patient experience group chat Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit. All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
Overall Study
Lost to Follow-up
1
2

Baseline Characteristics

The Effectiveness of SMS in Improving Antiretroviral Medication Adherence Among Adolescents Living With HIV in Nigeria

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Intervention Group
n=106 Participants
Daily ART-adherence SMS reminder Daily ART-adherence SMS reminder: Interactive and tailored SMS reminders that are acceptable to the participants to remind them to take their medications and to make clinic attendance. Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit. All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
Control Group
n=106 Participants
Standard adherence counselling/Patient experience group chat Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit. All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
Total
n=212 Participants
Total of all reporting groups
Age, Continuous
16.56 years
STANDARD_DEVIATION 1.41 • n=99 Participants
16.66 years
STANDARD_DEVIATION 1.36 • n=107 Participants
16.61 years
STANDARD_DEVIATION 1.38 • n=206 Participants
Sex: Female, Male
Female
51 Participants
n=99 Participants
53 Participants
n=107 Participants
104 Participants
n=206 Participants
Sex: Female, Male
Male
55 Participants
n=99 Participants
53 Participants
n=107 Participants
108 Participants
n=206 Participants
Race/Ethnicity, Customized
Yoruba
67 Participants
n=99 Participants
67 Participants
n=107 Participants
134 Participants
n=206 Participants
Race/Ethnicity, Customized
Hausa
3 Participants
n=99 Participants
2 Participants
n=107 Participants
5 Participants
n=206 Participants
Race/Ethnicity, Customized
Igbo
24 Participants
n=99 Participants
26 Participants
n=107 Participants
50 Participants
n=206 Participants
Race/Ethnicity, Customized
Others
12 Participants
n=99 Participants
11 Participants
n=107 Participants
23 Participants
n=206 Participants
Region of Enrollment
Nigeria
106 participants
n=99 Participants
106 participants
n=107 Participants
212 participants
n=206 Participants
Baseline ART Adherence (VAS)
VAS adherence (Self report of >/=95% adherence)
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Baseline ART Adherence (VAS)
Viral Load </= 20
54 Participants
n=99 Participants
49 Participants
n=107 Participants
103 Participants
n=206 Participants

PRIMARY outcome

Timeframe: 20week [End of study]

ART adherence is assessed by different well-validated methods. In this study, ART adherence will be measured, primarily, using the self-report visual analog scale. The scale is well-validated, self-report of the level of ART adherence with a range from 0 to 100%. While higher values indicate better levels of adherence, patients with adherence levels of 95% and above are regarded as ART-adherent while those with values less than 95% are not adherent to ART medications. Viral load is the number of copies of viral RNA detected in participants' blood. Participants with viral load \</=20 copies per ml are regarded to have optimal viral suppression indicative of optimal adherence to medications.

Outcome measures

Outcome measures
Measure
Intervention Group
n=105 Participants
Daily ART-adherence SMS reminder Daily ART-adherence SMS reminder: Interactive and tailored SMS reminders that are acceptable to the participants to remind them to take their medications and to make clinic attendance. Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit. All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
Control Group
n=104 Participants
Standard adherence counselling/Patient experience group chat Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit. All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
ART Adherence at 20 Weeks as Determined by VAS, Viral Load
Adherence by VAS
57 Participants
47 Participants
ART Adherence at 20 Weeks as Determined by VAS, Viral Load
Viral Load </= 20 copies
63 Participants
46 Participants

PRIMARY outcome

Timeframe: 20week [End of study]

AIDS Clinical Trials Group Scale scores range from 0 to 1. The higher scores reflect better ART adherence Pill count scores also range from 0 to 1 and the higher scores also reflect better adherence. Visual analog scale \[VAS\] adherence ranges between 0 and 100%. Higher scores reflect better ART adherence

Outcome measures

Outcome measures
Measure
Intervention Group
n=105 Participants
Daily ART-adherence SMS reminder Daily ART-adherence SMS reminder: Interactive and tailored SMS reminders that are acceptable to the participants to remind them to take their medications and to make clinic attendance. Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit. All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
Control Group
n=104 Participants
Standard adherence counselling/Patient experience group chat Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit. All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
ART Adherence at 20 Weeks as Determined by Pill Counts, ACTG Adherence Questionnaire, and VAS Scores
AIDS Clinical Trials Group Scale score
0.92 measurement vlaues and score on a scale
Standard Deviation 0.15
0.90 measurement vlaues and score on a scale
Standard Deviation 0.17
ART Adherence at 20 Weeks as Determined by Pill Counts, ACTG Adherence Questionnaire, and VAS Scores
Pill count score score
0.68 measurement vlaues and score on a scale
Standard Deviation 0.24
0.65 measurement vlaues and score on a scale
Standard Deviation 0.28
ART Adherence at 20 Weeks as Determined by Pill Counts, ACTG Adherence Questionnaire, and VAS Scores
VAS score, continuous
89.04 measurement vlaues and score on a scale
Standard Deviation 11.90
86.99 measurement vlaues and score on a scale
Standard Deviation 13.50

PRIMARY outcome

Timeframe: 20 week [End of study]

Viral load count is measured in copies per ml. The minimum value is 0. There is no maximum value. The higher values reflect poor adherence

Outcome measures

Outcome measures
Measure
Intervention Group
n=105 Participants
Daily ART-adherence SMS reminder Daily ART-adherence SMS reminder: Interactive and tailored SMS reminders that are acceptable to the participants to remind them to take their medications and to make clinic attendance. Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit. All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
Control Group
n=104 Participants
Standard adherence counselling/Patient experience group chat Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit. All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
ART Adherence at 20 Weeks as Determined by Viral Load Count
11678 copies/mL
Standard Deviation 51003.77
42676.71 copies/mL
Standard Deviation 147790.6

PRIMARY outcome

Timeframe: 20week [End of study]

log of viral load count is log 10 transformation of the viral load values

Outcome measures

Outcome measures
Measure
Intervention Group
n=105 Participants
Daily ART-adherence SMS reminder Daily ART-adherence SMS reminder: Interactive and tailored SMS reminders that are acceptable to the participants to remind them to take their medications and to make clinic attendance. Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit. All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
Control Group
n=104 Participants
Standard adherence counselling/Patient experience group chat Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit. All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
ART Adherence at 20 Weeks as Determined by Log of Viral Load Count
1.97 log10 copies/mL
Standard Deviation 1.30
2.63 log10 copies/mL
Standard Deviation 1.55

SECONDARY outcome

Timeframe: End of Study (20weeks)

Patient satisfaction will be assessed using a 22-item adaptation of the SERVQUAL tool. It is a multi-dimensional service quality assessment tool that uses a 5-point likert scale scored from 1 to 5 points to assess 5 domains of client satisfaction. The domains are tangibility (4 items; scores from 4 to 20), reliability (5 items; scores from 5 to 25), responsiveness (4 items; scores from 4 to 20), assurance (4 items; scores from 4 to 20), and empathy (5 items; scores from 5 to 25). Patient satisfaction is measured by the total score which will range between 22 and 110. Higher scores indicate better client satisfaction.

Outcome measures

Outcome measures
Measure
Intervention Group
n=105 Participants
Daily ART-adherence SMS reminder Daily ART-adherence SMS reminder: Interactive and tailored SMS reminders that are acceptable to the participants to remind them to take their medications and to make clinic attendance. Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit. All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
Control Group
n=104 Participants
Standard adherence counselling/Patient experience group chat Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit. All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
Patient Satisfaction Score at 20 Weeks
88.94 score on a scale
Standard Deviation 9.26
91.76 score on a scale
Standard Deviation 8.72

SECONDARY outcome

Timeframe: End of study (20weeks)

The General Health Questionnaire 12 (GHQ12) will be used to assess the mental health status of all the participants. It is a well-validated and widely used instrument for screening for mental health distress. It is a 12-item questionnaire that is based on a 4-point likert scale scored from 0 to 3 points. The scores will range between 0 and 36. A score of 12 or more is suggestive of mental distress while scores less than 12 suggest that mental distress is absent.

Outcome measures

Outcome measures
Measure
Intervention Group
n=105 Participants
Daily ART-adherence SMS reminder Daily ART-adherence SMS reminder: Interactive and tailored SMS reminders that are acceptable to the participants to remind them to take their medications and to make clinic attendance. Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit. All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
Control Group
n=104 Participants
Standard adherence counselling/Patient experience group chat Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit. All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
Number of Participants With Mental Distress Determined by General Health Questionnaire 12 at 20 Weeks
2 Participants
11 Participants

Adverse Events

Intervention Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Olumide ABIODUN

Babcock University

Phone: 07038569725

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place